skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Results 1 - 20 of 989  for All Library Resources

Results 1 2 3 4 5 next page
Show only
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Neutralization of SARS-CoV-2 Variants B.1.429 and B.1.351
Material Type:
Article
Add to My Research

Neutralization of SARS-CoV-2 Variants B.1.429 and B.1.351

New England Journal of Medicine, 2021-06, Vol.384 (24), p.2352-2354 [Peer Reviewed Journal]

Copyright © 2021 Massachusetts Medical Society. All rights reserved. ;2021. Not withstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://www.nejm.org/about-nejm/permissions?query=footer ;Copyright © 2021 Massachusetts Medical Society. All rights reserved. 2021 Massachusetts Medical Society ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMc2103740 ;PMID: 33826819

Digital Resources/Online E-Resources

2
A Bivalent Omicron-Containing Booster Vaccine against Covid-19
Material Type:
Article
Add to My Research

A Bivalent Omicron-Containing Booster Vaccine against Covid-19

The New England journal of medicine, 2022-10, Vol.387 (14), p.1279-1291 [Peer Reviewed Journal]

Copyright © 2022 Massachusetts Medical Society. All rights reserved. ;COPYRIGHT 2022 Massachusetts Medical Society ;Copyright © 2022 Massachusetts Medical Society. All rights reserved. 2022 Massachusetts Medical Society ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa2208343 ;PMID: 36112399

Full text available

3
SARS-CoV-2 variant B.1.1.7 is susceptible to neutralizing antibodies elicited by ancestral spike vaccines
Material Type:
Article
Add to My Research

SARS-CoV-2 variant B.1.1.7 is susceptible to neutralizing antibodies elicited by ancestral spike vaccines

Cell host & microbe, 2021-04, Vol.29 (4), p.529-539.e3 [Peer Reviewed Journal]

2021 Elsevier Inc. ;Copyright © 2021 Elsevier Inc. All rights reserved. ;COPYRIGHT 2021 Elsevier B.V. ;2021 Elsevier Inc. 2021 Elsevier Inc. ;ISSN: 1931-3128 ;EISSN: 1934-6069 ;DOI: 10.1016/j.chom.2021.03.002 ;PMID: 33705729

Full text available

4
SnapShot: SARS-CoV-2 antibodies
Material Type:
Article
Add to My Research

SnapShot: SARS-CoV-2 antibodies

Cell host & microbe, 2021-07, Vol.29 (7), p.1162-1162.e1 [Peer Reviewed Journal]

2021 Elsevier Inc. ;2021 Elsevier Inc. 2021 Elsevier Inc. ;ISSN: 1931-3128 ;EISSN: 1934-6069 ;DOI: 10.1016/j.chom.2021.06.005 ;PMID: 34265246

Full text available

5
D614G Spike Mutation Increases SARS CoV-2 Susceptibility to Neutralization
Material Type:
Article
Add to My Research

D614G Spike Mutation Increases SARS CoV-2 Susceptibility to Neutralization

Cell Host & Microbe, 2021-01, Vol.29 (1), p.23-31.e4 [Peer Reviewed Journal]

2020 ;Copyright © 2020. Published by Elsevier Inc. ;2020. Not withstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://www.elsevier.com/legal/elsevier-website-terms-and-conditions ;2020 Published by Elsevier Inc. 2020 ;ISSN: 1931-3128 ;EISSN: 1934-6069 ;DOI: 10.1016/j.chom.2020.11.012 ;PMID: 33306985

Digital Resources/Online E-Resources

6
Potential of conventional & bispecific broadly neutralizing antibodies for prevention of HIV-1 subtype A, C & D infections
Material Type:
Article
Add to My Research

Potential of conventional & bispecific broadly neutralizing antibodies for prevention of HIV-1 subtype A, C & D infections

PLoS pathogens, 2018-03, Vol.14 (3), p.e1006860-e1006860 [Peer Reviewed Journal]

COPYRIGHT 2018 Public Library of Science ;COPYRIGHT 2018 Public Library of Science ;2018 Public Library of Science. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited: Wagh K, Seaman MS, Zingg M, Fitzsimons T, Barouch DH, Burton DR, et al. (2018) Potential of conventional & bispecific broadly neutralizing antibodies for prevention of HIV-1 subtype A, C & D infections. PLoS Pathog 14(3): e1006860. https://doi.org/10.1371/journal.ppat.1006860 ;2018 Public Library of Science. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited: Wagh K, Seaman MS, Zingg M, Fitzsimons T, Barouch DH, Burton DR, et al. (2018) Potential of conventional & bispecific broadly neutralizing antibodies for prevention of HIV-1 subtype A, C & D infections. PLoS Pathog 14(3): e1006860. https://doi.org/10.1371/journal.ppat.1006860 ;ISSN: 1553-7374 ;ISSN: 1553-7366 ;EISSN: 1553-7374 ;DOI: 10.1371/journal.ppat.1006860 ;PMID: 29505593

Full text available

7
Optimal Combinations of Broadly Neutralizing Antibodies for Prevention and Treatment of HIV-1 Clade C Infection
Material Type:
Article
Add to My Research

Optimal Combinations of Broadly Neutralizing Antibodies for Prevention and Treatment of HIV-1 Clade C Infection

PLoS pathogens, 2016-03, Vol.12 (3), p.e1005520-e1005520 [Peer Reviewed Journal]

COPYRIGHT 2016 Public Library of Science ;COPYRIGHT 2016 Public Library of Science ;2016 Public Library of Science. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited: Wagh K, Bhattacharya T, Williamson C, Robles A, Bayne M, Garrity J, et al. (2016) Optimal Combinations of Broadly Neutralizing Antibodies for Prevention and Treatment of HIV-1 Clade C Infection. PLoS Pathog 12(3): e1005520. doi:10.1371/journal.ppat.1005520 ;2016 Public Library of Science. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited: Wagh K, Bhattacharya T, Williamson C, Robles A, Bayne M, Garrity J, et al. (2016) Optimal Combinations of Broadly Neutralizing Antibodies for Prevention and Treatment of HIV-1 Clade C Infection. PLoS Pathog 12(3): e1005520. doi:10.1371/journal.ppat.1005520 ;ISSN: 1553-7374 ;ISSN: 1553-7366 ;EISSN: 1553-7374 ;DOI: 10.1371/journal.ppat.1005520 ;PMID: 27028935

Full text available

8
Safety and immunogenicity of SARS-CoV-2 variant mRNA vaccine boosters in healthy adults: an interim analysis
Material Type:
Article
Add to My Research

Safety and immunogenicity of SARS-CoV-2 variant mRNA vaccine boosters in healthy adults: an interim analysis

Nature medicine, 2021-11, Vol.27 (11), p.2025-2031 [Peer Reviewed Journal]

2021. The Author(s). ;COPYRIGHT 2021 Nature Publishing Group ;The Author(s) 2021. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2021 ;ISSN: 1078-8956 ;EISSN: 1546-170X ;DOI: 10.1038/s41591-021-01527-y ;PMID: 34526698

Full text available

9
Structural diversity of the SARS-CoV-2 Omicron spike
Material Type:
Article
Add to My Research

Structural diversity of the SARS-CoV-2 Omicron spike

Molecular cell, 2022-06, Vol.82 (11), p.2050-2068.e6 [Peer Reviewed Journal]

2022 Elsevier Inc. ;Copyright © 2022 Elsevier Inc. All rights reserved. ;2022 Elsevier Inc. 2022 Elsevier Inc. ;ISSN: 1097-2765 ;EISSN: 1097-4164 ;DOI: 10.1016/j.molcel.2022.03.028 ;PMID: 35447081

Full text available

10
Bispecific Antibodies Against HIV
Material Type:
Article
Add to My Research

Bispecific Antibodies Against HIV

Cell, 2016-06, Vol.165 (7), p.1563-1564 [Peer Reviewed Journal]

2016 Elsevier Inc. ;Copyright © 2016 Elsevier Inc. All rights reserved. ;ISSN: 0092-8674 ;EISSN: 1097-4172 ;DOI: 10.1016/j.cell.2016.06.004 ;PMID: 27315470

Full text available

11
Sequential and Simultaneous Immunization of Rabbits with HIV-1 Envelope Glycoprotein SOSIP.664 Trimers from Clades A, B and C
Material Type:
Article
Add to My Research

Sequential and Simultaneous Immunization of Rabbits with HIV-1 Envelope Glycoprotein SOSIP.664 Trimers from Clades A, B and C

PLoS pathogens, 2016-09, Vol.12 (9), p.e1005864-e1005864 [Peer Reviewed Journal]

COPYRIGHT 2016 Public Library of Science ;COPYRIGHT 2016 Public Library of Science ;2016 Public Library of Science. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited: Klasse PJ, LaBranche CC, Ketas TJ, Ozorowski G, Cupo A, Pugach P, et al. (2016) Sequential and Simultaneous Immunization of Rabbits with HIV-1 Envelope Glycoprotein SOSIP.664 Trimers from Clades A, B and C. PLoS Pathog 12(9): e1005864. doi:10.1371/journal.ppat.1005864 ;2016 Klasse et al 2016 Klasse et al ;2016 Public Library of Science. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited: Klasse PJ, LaBranche CC, Ketas TJ, Ozorowski G, Cupo A, Pugach P, et al. (2016) Sequential and Simultaneous Immunization of Rabbits with HIV-1 Envelope Glycoprotein SOSIP.664 Trimers from Clades A, B and C. PLoS Pathog 12(9): e1005864. doi:10.1371/journal.ppat.1005864 ;ISSN: 1553-7374 ;ISSN: 1553-7366 ;EISSN: 1553-7374 ;DOI: 10.1371/journal.ppat.1005864 ;PMID: 27627672

Full text available

12
The SARS-CoV-2 Spike variant D614G favors an open conformational state
Material Type:
Article
Add to My Research

The SARS-CoV-2 Spike variant D614G favors an open conformational state

Science advances, 2021-04, Vol.7 (16) [Peer Reviewed Journal]

Copyright © 2021 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works. Distributed under a Creative Commons Attribution NonCommercial License 4.0 (CC BY-NC). ;Copyright © 2021 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works. Distributed under a Creative Commons Attribution NonCommercial License 4.0 (CC BY-NC). 2021 The Authors ;ISSN: 2375-2548 ;EISSN: 2375-2548 ;DOI: 10.1126/sciadv.abf3671 ;PMID: 33863729

Full text available

13
Evaluation of mRNA-1273 Covid-19 Vaccine in Children 6 to 11 Years of Age
Material Type:
Article
Add to My Research

Evaluation of mRNA-1273 Covid-19 Vaccine in Children 6 to 11 Years of Age

New England Journal of Medicine, 2022-05, Vol.386 (21), p.2011-2023 [Peer Reviewed Journal]

Copyright © 2022 Massachusetts Medical Society. All rights reserved. ;Copyright © 2022 Massachusetts Medical Society. ;COPYRIGHT 2022 Massachusetts Medical Society ;2022. Not withstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://www.nejm.org/about-nejm/permissions?query=footer ;Copyright © 2022 Massachusetts Medical Society. All rights reserved. 2022 Massachusetts Medical Society ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa2203315 ;PMID: 35544369

Digital Resources/Online E-Resources

14
Towards a population-based threshold of protection for COVID-19 vaccines
Material Type:
Article
Add to My Research

Towards a population-based threshold of protection for COVID-19 vaccines

Vaccine, 2022-01, Vol.40 (2), p.306-315 [Peer Reviewed Journal]

2021 The Author(s) ;Copyright © 2021 The Author(s). Published by Elsevier Ltd.. All rights reserved. ;2021. The Author(s) ;2021 The Author(s) 2021 ;ISSN: 0264-410X ;EISSN: 1873-2518 ;DOI: 10.1016/j.vaccine.2021.12.006 ;PMID: 34933765

Full text available

15
Epitopes for neutralizing antibodies induced by HIV-1 envelope glycoprotein BG505 SOSIP trimers in rabbits and macaques
Material Type:
Article
Add to My Research

Epitopes for neutralizing antibodies induced by HIV-1 envelope glycoprotein BG505 SOSIP trimers in rabbits and macaques

PLoS pathogens, 2018-02, Vol.14 (2), p.e1006913-e1006913 [Peer Reviewed Journal]

COPYRIGHT 2018 Public Library of Science ;COPYRIGHT 2018 Public Library of Science ;2018 Public Library of Science. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited: Klasse PJ, Ketas TJ, Cottrell CA, Ozorowski G, Debnath G, Camara D, et al. (2018) Epitopes for neutralizing antibodies induced by HIV-1 envelope glycoprotein BG505 SOSIP trimers in rabbits and macaques. PLoS Pathog 14(2): e1006913. https://doi.org/10.1371/journal.ppat.1006913 ;2018 Klasse et al 2018 Klasse et al ;2018 Public Library of Science. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited: Klasse PJ, Ketas TJ, Cottrell CA, Ozorowski G, Debnath G, Camara D, et al. (2018) Epitopes for neutralizing antibodies induced by HIV-1 envelope glycoprotein BG505 SOSIP trimers in rabbits and macaques. PLoS Pathog 14(2): e1006913. https://doi.org/10.1371/journal.ppat.1006913 ;ISSN: 1553-7374 ;ISSN: 1553-7366 ;EISSN: 1553-7374 ;DOI: 10.1371/journal.ppat.1006913 ;PMID: 29474444

Full text available

16
Vaccine-induced plasma IgA specific for the C1 region of the HIV-1 envelope blocks binding and effector function of IgG
Material Type:
Article
Add to My Research

Vaccine-induced plasma IgA specific for the C1 region of the HIV-1 envelope blocks binding and effector function of IgG

Proceedings of the National Academy of Sciences - PNAS, 2013-05, Vol.110 (22), p.9019-9024 [Peer Reviewed Journal]

copyright © 1993-2008 National Academy of Sciences of the United States of America ;Copyright National Academy of Sciences May 28, 2013 ;ISSN: 0027-8424 ;EISSN: 1091-6490 ;DOI: 10.1073/pnas.1301456110 ;PMID: 23661056

Full text available

17
Global Panel of HIV-1 Env Reference Strains for Standardized Assessments of Vaccine-Elicited Neutralizing Antibodies
Material Type:
Article
Add to My Research

Global Panel of HIV-1 Env Reference Strains for Standardized Assessments of Vaccine-Elicited Neutralizing Antibodies

Journal of Virology, 2014-03, Vol.88 (5), p.2489-2507 [Peer Reviewed Journal]

Copyright © 2014, American Society for Microbiology. All Rights Reserved. 2014 American Society for Microbiology ;ISSN: 0022-538X ;EISSN: 1098-5514 ;DOI: 10.1128/JVI.02853-13 ;PMID: 24352443

Full text available

18
Vaccine-induced IgG antibodies to V1V2 regions of multiple HIV-1 subtypes correlate with decreased risk of HIV-1 infection
Material Type:
Article
Add to My Research

Vaccine-induced IgG antibodies to V1V2 regions of multiple HIV-1 subtypes correlate with decreased risk of HIV-1 infection

PloS one, 2014-02, Vol.9 (2), p.e87572-e87572 [Peer Reviewed Journal]

COPYRIGHT 2014 Public Library of Science ;COPYRIGHT 2014 Public Library of Science ;2014. This is an open-access article, free of all copyright, and may be freely reproduced, distributed, transmitted, modified, built upon, or otherwise used by anyone for any lawful purpose. The work is made available under the Creative Commons CC0 public domain dedication. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2014 ;ISSN: 1932-6203 ;EISSN: 1932-6203 ;DOI: 10.1371/journal.pone.0087572 ;PMID: 24504509

Full text available

19
Enhanced immunity after Ad26.COV2.S vaccine breakthrough infection
Material Type:
Article
Add to My Research

Enhanced immunity after Ad26.COV2.S vaccine breakthrough infection

Cell reports. Medicine, 2022-03, Vol.3 (3), p.100579, Article 100579 [Peer Reviewed Journal]

2022 The Author(s) ;2022 The Author(s). ;2022 The Author(s) 2022 ;ISSN: 2666-3791 ;EISSN: 2666-3791 ;DOI: 10.1016/j.xcrm.2022.100579 ;PMID: 35474738

Full text available

20
Evidence that Ecotropic Murine Leukemia Virus Contamination in TZM-bl Cells Does Not Affect the Outcome of Neutralizing Antibody Assays with Human Immunodeficiency Virus Type 1
Material Type:
Article
Add to My Research

Evidence that Ecotropic Murine Leukemia Virus Contamination in TZM-bl Cells Does Not Affect the Outcome of Neutralizing Antibody Assays with Human Immunodeficiency Virus Type 1

Journal of Virology, 2009-08, Vol.83 (16), p.8289-8292 [Peer Reviewed Journal]

2009 INIST-CNRS ;Copyright © 2009, American Society for Microbiology ;ISSN: 0022-538X ;EISSN: 1098-5514 ;DOI: 10.1128/JVI.00709-09 ;PMID: 19474095

Full text available

Results 1 - 20 of 989  for All Library Resources

Results 1 2 3 4 5 next page

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Show only

  1. Peer-reviewed Journals (897)

Refine My Results

Creation Date 

From To
  1. Before 1989  (19)
  2. 1989 To 1996  (42)
  3. 1997 To 2004  (147)
  4. 2005 To 2013  (314)
  5. After 2013  (468)
  6. More options open sub menu

Resource Type 

  1. Articles  (941)
  2. Patents  (48)
  3. More options open sub menu

Language 

  1. English  (987)
  2. Japanese  (101)
  3. French  (29)
  4. German  (10)
  5. Portuguese  (1)
  6. Russian  (1)
  7. More options open sub menu

Searching Remote Databases, Please Wait